REGOLA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 946
AS - Asia 714
EU - Europa 533
SA - Sud America 127
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 24
AF - Africa 20
Totale 2.391
Nazione #
US - Stati Uniti d'America 918
SG - Singapore 274
CN - Cina 177
IT - Italia 161
DE - Germania 104
BR - Brasile 100
HK - Hong Kong 93
VN - Vietnam 61
FI - Finlandia 55
FR - Francia 37
GB - Regno Unito 34
UA - Ucraina 32
RU - Federazione Russa 24
AU - Australia 23
BD - Bangladesh 17
IN - India 17
TR - Turchia 17
IE - Irlanda 16
CA - Canada 15
NL - Olanda 14
AR - Argentina 11
JP - Giappone 11
SE - Svezia 11
GR - Grecia 9
MX - Messico 9
IQ - Iraq 8
PK - Pakistan 8
AT - Austria 7
EG - Egitto 7
MK - Macedonia 7
PL - Polonia 6
CO - Colombia 5
ES - Italia 5
PH - Filippine 4
TH - Thailandia 4
TN - Tunisia 4
CH - Svizzera 3
EC - Ecuador 3
JO - Giordania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
ET - Etiopia 2
ID - Indonesia 2
IR - Iran 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
Totale 2.364
Città #
Singapore 164
Ashburn 103
Hong Kong 89
San Jose 67
Fairfield 65
Beijing 53
Helsinki 42
New York 38
The Dalles 38
Los Angeles 31
Munich 31
Chandler 30
Brescia 28
Houston 27
Jacksonville 25
Princeton 25
Council Bluffs 24
Woodbridge 23
Cambridge 22
Ho Chi Minh City 22
Wilmington 22
Dallas 21
Seattle 21
Milan 17
Lauterbourg 16
Ann Arbor 15
Dublin 15
Hanoi 15
Sydney 14
Istanbul 13
Rome 12
Buffalo 11
Columbus 11
Turku 11
Orem 10
San Francisco 9
Brooklyn 8
San Diego 8
São Paulo 8
Athens 7
Chicago 7
Montreal 7
Nuremberg 7
Shanghai 7
Stockholm 7
Amsterdam 6
Bergamo 6
Cairo 6
Mexico City 6
Redondo Beach 6
Baghdad 5
Frankfurt am Main 5
Melbourne 5
Rho 5
Santa Clara 5
Adelaide 4
Bosio 4
Changsha 4
Des Moines 4
Dosso 4
Louisville 4
Moscow 4
Phoenix 4
Porto Alegre 4
Rawalpindi 4
Tokyo 4
Amman 3
Atlanta 3
Brasília 3
Catania 3
City of London 3
Curitiba 3
Denver 3
Dhaka 3
Duncan 3
Falkenstein 3
Gothenburg 3
London 3
Lucknow 3
Manchester 3
Redwood City 3
Shenyang 3
Skopje 3
Toledo 3
Abu Dhabi 2
Addis Ababa 2
Bagheria 2
Bangkok 2
Bauru 2
Belo Horizonte 2
Bengaluru 2
Biên Hòa 2
Bratislava 2
Buenos Aires 2
Cincinnati 2
Corte Franca 2
Cosenza 2
Cuenca 2
Genoa 2
Haikou 2
Totale 1.431
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 221
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
DEVELOPMENT OF NEW PERSONALIZED DIAGNOSTIC AND THERAPEUTIC STRATEGIES IN GIANT CELL ARTERITIS: IDENTIFICATION OF NEW MARKERS FOR DISEASE SUBSETS AND PREDICTORS OF THERAPEUTIC RESPONSE 175
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 171
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 144
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 139
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 138
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 120
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 96
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 96
Can we use NOACS in APS? 95
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade 93
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade 87
Novel Therapies in Takayasu Arteritis. 84
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 80
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 77
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 73
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 63
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review 34
Giant cell arteritis in clinical practice: beyond GiACTA 10
Totale 2.391
Categoria #
all - tutte 12.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022124 0 16 10 4 4 6 5 11 7 15 21 25
2022/202393 15 1 3 5 10 29 0 10 11 0 6 3
2023/2024162 13 3 21 14 5 30 3 16 35 1 5 16
2024/2025535 7 13 8 51 28 38 68 23 29 66 130 74
2025/20261.013 94 118 70 144 105 75 142 44 80 84 35 22
2026/202791 47 44 0 0 0 0 0 0 0 0 0 0
Totale 2.391